PDF
Word
This version of the form is not currently in use and is provided for reference only. Download this version of
Form HLTH5338
for the current year.
Form HLTH5338 Special Authority Request - Dalteparin / Enoxaparin / Nadroparin / Tinzaparin Low Molecular Weight Heparin - British Columbia, Canada
Form HLTH5338 Special Authority Request - Dalteparin/Enoxaparin/Nadroparin/Tinzaparin Low Molecular Weight Heparin is used in British Columbia, Canada to request special authority for coverage of these specific types of low molecular weight heparin medications.
The Form HLTH5338 Special Authority Request for Dalteparin/Enoxaparin/Nadroparin/Tinzaparin Low Molecular Weight Heparin in British Columbia, Canada is filed by healthcare providers or physicians on behalf of their patients.
FAQ
Q: What is the Form HLTH5338?
A: Form HLTH5338 is a special authority request form for Dalteparin/Enoxaparin/Nadroparin/Tinzaparin low molecular weight heparin in British Columbia, Canada.
Q: What is Dalteparin/Enoxaparin/Nadroparin/Tinzaparin?
A: Dalteparin/Enoxaparin/Nadroparin/Tinzaparin are types of low molecular weight heparin.
Q: Who can use Form HLTH5338?
A: Form HLTH5338 can be used by patients in British Columbia, Canada who need Dalteparin/Enoxaparin/Nadroparin/Tinzaparin low molecular weight heparin.
Q: What is special authority?
A: Special authority is a process in British Columbia, Canada where specific medications require approval before they are covered by provincial drug plans.
